GE HealthCare Receives FDA 510(k) Clearance and CE Mark for Allia Moveo

Reuters
02/02
GE HealthCare Receives FDA 510(k) Clearance and CE Mark for Allia Moveo

GE HealthCare Technologies Inc. announced that its Allia Moveo platform has received U.S. Food and Drug Administration (FDA) 510(k) clearance and CE Marking. The Allia Moveo system is designed to enhance mobility and precision in the interventional suite, supporting a range of cardiovascular, vascular, non-vascular, and surgical procedures. The platform incorporates AI-powered guidance tools and offers a compact, cable-free C-arm system. The first U.S. installation of Allia Moveo took place at Baylor St. Luke's Medical Center in Houston, following its initial global deployment at Hôpital Marie-Lannelongue.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GE HealthCare Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260130422339) on February 02, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10